Chapter 1 - Final Solution: Vaccines or Bust

This is a listing of all citations in this chapter.

121

Centers for Disease Control and Prevention, “Public health investigations of COVID-19 vaccine breakthrough cases,” CDC.

122

Zeke Miller, “Biden Grappling With ‘Pandemic of the Unvaccinated’,” NBC New York, Jul. 17, 2021.

123

Virginia Langmaid, “Data on hospitalizations and deaths in the unvaccinated do not reflect Delta variant, CDC director says,” CNN (Aug. 5, 2021).

124

Our World in Data, “COVID-19 vaccination doses administered per 100 people, Jan 1, 2021,” Our World in Data (Jan. 1, 2021).

125

Our World in Data, “COVID-19 vaccination doses administered per 100 people, Apr 15, 2021,” Our World in Data (Apr. 15, 2021).

126

Our World in Data, “COVID-19 vaccination doses administered per 100 people, Jun. 15, 2021,” Our World in Data, (Jun. 15, 2021).

127

Yasmeen Abutaleb and Lena Sun, “How CDC Data Problems Put the U.S. Behind on the Delta Variant,” Washington Post, Aug. 19, 2021.

128

Megan Redshaw, “Reports of Serious Injuries After COVID Vaccines Near 112,000, as Pfizer Asks FDA to Green Light Shots for Kids 5 to 11,” The Defender, Oct. 8, 2021.

129

Victoria Male, “Menstrual changes after covid-19 vaccination” The BMJ (2021) 374

130

MedAlerts, “5,990 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Symptom is Amenorrhoea or Dysmenorrhoea or Menopausal disorder or Menopausal symptoms or Menopause or Menopause delayed or Menstrual discomfort or Menstrual disorder or Menstruation delayed or Menstruation irregular,” MedAlerts/VAERS, (Oct. 1, 2021). *Original data has been deleted from Archive.org, updated link represents 7,463 VAERS reports filed as of 12/3/2021.

131

Sue Hughes, “CVST After COVID-19 Vaccine: New Data Confirm High Mortality Rate,” Medscape (Sept. 30, 2021).

132

Ruud Lensen et al., “Hepatitis C Virus Reactivation Following COVID-19 Vaccination—A Case Report.” PubMed Int Med Case Rep J 2021; 14: 573–576.

133

Jason Calvi, “Senator Johnson, Families Speak: COVID Vaccine Adverse Reactions,” FOX6, Jun. 28, 2021.

134

Bill Chappelle, “Pfizer Says COVID-19 Vaccine Shows ‘100% Efficacy’ In Adolescents,” NPR, Mar. 31, 2021.

135

Centers for Disease Control and Prevention, “Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020,” MMWR (Mar. 27, 2020).

136

“Pfizer Vaccine Kills More Than It Saves,” Steve Kirsch VRBPAC Meeting, Sep. 17, 2021.

137

Ronald N. Kostoff et al, “Why are we vaccinating children against COVID-19?” Toxicology Reports, 8 (2021): 1665–1684.

138

MedAlerts, “Found 7,537 cases where Vaccine is COVID19 and Symptom is Myocarditis or Myopericarditis or Pericarditis,”MedAlert/VAERS (Oct. 1, 2021).

139

MedAlerts, “Found 5,602 cases where Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Symptom is Myocarditis or Pericarditis,” MedAlert/VAERS (Oct. 1, 2021).

140

MedAlerts, “Found 476 cases where Age is 12-or-more-and-under-18 and Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Symptom is Myocarditis or Pericarditis,”MedAlerts/VAERS (Oct. 1, 2021).

141

Jessica Rose PhD, MSc, BSc and Peter A. McCullough MD, MPH, “A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products.” ScienceDirect Current Problems in Cardiology. In Press, Journal Pre-proof (Oct. 1, 2021).

142

CDC, “June 23, 2021 ACIP Meeting,” YouTube, 01:26:39, Jun. 23, 2021.

143

Michael Kang, “Viral Myocarditis,” StatPearls (Updated 2021 Aug. 11).

144

Megan Redshaw, “Sweden, Denmark Pause Moderna’s COVID Vaccine for Younger Age Groups Citing Reports of Myocarditis,” The Defender (Oct. 6, 2021).

145

Essi Lehto, “Finland joins Sweden and Denmark in limiting Moderna COVID-19 vaccine,” Reuters (Oct. 7, 2021).

146

FDA, “Letter to Amit Patel, Pfizer Inc., BioNTech Manufacturing GmbH-BLA Approval.” U.S. Food & Drug Administration (Aug. 23, 2021).

147

Clinical Trials-NIH, “Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates against COVID-19 in Healthy Individuals,” NIH, Apr. 29, 2020-May 15, 2023.

148

Mehul Suthar et al., “Durability of immune responses to the BNT162b2 mRNA vaccine,” BioRxiv preprint (Oct. 2021).

149

Maggie Fox, “Studies confirm waning immunity from Pfizer’s Covid-19 vaccine,” CNN (Oct. 7, 2021).

150

Sara Y. Tartof, Ph.D. et al., “Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.” The Lancet (Oct. 4, 2021).